BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12393523)

  • 1. The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells.
    Tonks A; Pearn L; Tonks AJ; Pearce L; Hoy T; Phillips S; Fisher J; Downing JR; Burnett AK; Darley RL
    Blood; 2003 Jan; 101(2):624-32. PubMed ID: 12393523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.
    Tonks A; Tonks AJ; Pearn L; Pearce L; Hoy T; Couzens S; Fisher J; Burnett AK; Darley RL
    Leukemia; 2004 Jul; 18(7):1238-45. PubMed ID: 15152269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation.
    Bäsecke J; Schwieger M; Griesinger F; Schiedlmeier B; Wulf G; Trümper L; Stocking C
    Leuk Lymphoma; 2005 Feb; 46(2):265-72. PubMed ID: 15621811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.
    Mulloy JC; Cammenga J; MacKenzie KL; Berguido FJ; Moore MA; Nimer SD
    Blood; 2002 Jan; 99(1):15-23. PubMed ID: 11756147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1.
    Choi Y; Elagib KE; Delehanty LL; Goldfarb AN
    Cancer Res; 2006 Mar; 66(6):2990-6. PubMed ID: 16540647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression.
    Yeh JR; Munson KM; Chao YL; Peterson QP; Macrae CA; Peterson RT
    Development; 2008 Jan; 135(2):401-10. PubMed ID: 18156164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
    Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
    Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation.
    de Guzman CG; Warren AJ; Zhang Z; Gartland L; Erickson P; Drabkin H; Hiebert SW; Klug CA
    Mol Cell Biol; 2002 Aug; 22(15):5506-17. PubMed ID: 12101243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
    Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
    J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the ETO and AML1-ETO proteins involved in 8;21 translocation in acute myelogenous leukemia.
    Le XF; Claxton D; Kornblau S; Fan YH; Mu ZM; Chang KS
    Eur J Haematol; 1998 Apr; 60(4):217-25. PubMed ID: 9579874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML-1-ETO-Mediated erythroid inhibition: new paradigms for differentiation blockade by a leukemic fusion protein.
    Choi Y; Elagib KE; Goldfarb AN
    Crit Rev Eukaryot Gene Expr; 2005; 15(3):207-16. PubMed ID: 16390317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
    Goyama S; Schibler J; Gasilina A; Shrestha M; Lin S; Link KA; Chen J; Whitman SP; Bloomfield CD; Nicolet D; Assi SA; Ptasinska A; Heidenreich O; Bonifer C; Kitamura T; Nassar NN; Mulloy JC
    Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.
    Yan M; Burel SA; Peterson LF; Kanbe E; Iwasaki H; Boyapati A; Hines R; Akashi K; Zhang DE
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17186-91. PubMed ID: 15569932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element.
    Mulloy JC; Cammenga J; Berguido FJ; Wu K; Zhou P; Comenzo RL; Jhanwar S; Moore MA; Nimer SD
    Blood; 2003 Dec; 102(13):4369-76. PubMed ID: 12946995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.
    Rhoades KL; Hetherington CJ; Harakawa N; Yergeau DA; Zhou L; Liu LQ; Little MT; Tenen DG; Zhang DE
    Blood; 2000 Sep; 96(6):2108-15. PubMed ID: 10979955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
    Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
    Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ETO domain is necessary for the developmental abnormalities associated with AML1-ETO expression in the hematopoietic stem cell compartment in vivo.
    de Guzman CG; Johnson A; Klug CA
    Blood Cells Mol Dis; 2003; 30(2):201-6. PubMed ID: 12732184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
    Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H
    Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.
    Okuda T; Cai Z; Yang S; Lenny N; Lyu CJ; van Deursen JM; Harada H; Downing JR
    Blood; 1998 May; 91(9):3134-43. PubMed ID: 9558367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
    Shimada H; Ichikawa H; Ohki M
    Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.